Get the Stockscreener App
147.37
1.82%
2.64
After Hours:
147.37
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $147.37, with a volume of 871.17K.
It is up +1.82% in the last 24 hours and down -9.58% over the past month.
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$144.73
Open:
$144.97
24h Volume:
871.17K
Relative Volume:
1.23
Market Cap:
$8.01B
Revenue:
$1.97B
Net Income/Loss:
$-494.50M
P/E Ratio:
-15.98
EPS:
-9.22
Net Cash Flow:
$137.20M
1W Performance:
-8.62%
1M Performance:
-9.58%
6M Performance:
-16.69%
1Y Performance:
+16.16%
1-Day Range:
$144.27
$149.66
1-Week Range:
$135.83
$164.32
52-Week Range:
$107.98
$194.88
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
147.37 | 7.86B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
131.36 | 233.71B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.75 | 152.83B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
376.67 | 144.35B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.74 | 119.00B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.16 | 46.00B | 5.69B | 4.14B | 577.90M | 6.96 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Mutual of America Capital Management LLC Has $3.81 Million Stock Holdings in Masimo Corporation (NASDAQ:MASI) - Defense World
Will breakout in Masimo Corporation lead to full recoveryWeekly Signal Report with Trend Summary - Newser
Masimo Reports Fiscal 2025 Q2 Results: Revenues +8%, Op Profits +54%, EPS +78%; So Why Did Its Stock Drop 12%? - Strata-gee.com
Masimo (NASDAQ:MASI) Price Target Raised to $210.00 at Piper Sandler - MarketBeat
Masimo Corporation (NASDAQ:MASI) Q2 2025 Earnings Call Transcript - Insider Monkey
Is Masimo Corporation stock reversal real or fakeChart Scanner for Swing Trade Timing - Newser
Masimo Corp. Reports Strong Q2 2025 Growth - The Globe and Mail
Masimo Corp. Earnings Call Highlights Growth and Resilience - TipRanks
Masimo Drops Founder Joe Kiani From 'Empty Voting' Suit - Law360
MASI Stock Slips Despite Q2 Earnings and Revenue Beat, Margins Expand - Yahoo Finance
Masimo price target raised to $210 from $200 at Piper Sandler - TipRanks
Stifel reiterates Buy rating on Masimo stock after solid Q2 earnings - Investing.com
Stifel Reiterates Buy Rating on Masimo Corp. (MASI) - StreetInsider
Needham reiterates Hold rating on Masimo stock after Q2 earnings beat - Investing.com India
Jefferies raises Masimo stock price target to $170 on lower tariff impact - Investing.com Nigeria
Masimo: Q2 Earnings Snapshot - Huron Daily Tribune
Masimo Corp. Exceeds Expectations in Second-Quarter EarningsNews and Statistics - IndexBox
Masimo Corp (MASI) Q2 2025 Earnings Call Highlights: Strong EPS Growth and Strategic ... - Yahoo Finance
Masimo Corp (MASI) Q2 2025 Earnings Call Highlights: Strong EPS Growth and Strategic Initiatives Propel Performance - GuruFocus
Masimo Corp (MASI) Q2 2025 Earnings Call Highlights: Strong EPS Growth and Strategic ... By GuruFocus - Investing.com Canada
Masimo Raised Its Outlook But Investors Weren’t Impressed - Finimize
Earnings call transcript: Masimo Q2 2025 beats forecasts, stock gains By Investing.com - Investing.com Canada
MASIMO CORP SEC 10-Q Report - TradingView
Masimo Q2 2025 slides: 46% EPS growth despite tariff headwinds, guidance raised - Investing.com Australia
Masimo earnings beat by $0.11, revenue topped estimates - Investing.com
Masimo (MASI) files 8-K referencing Q2 2025 results | MASI SEC FilingForm 8-K - Stock Titan
Masimo Crushes Earnings Expectations with 46% EPS Growth, Raises 2025 Outlook Despite Tariff Headwinds - Stock Titan
What makes Masimo Corporation stock price move sharplyMarket Momentum Signal Generator Shows Trends - metal.it
What drives Masimo Corporation stock priceBuild a diversified portfolio for stability - Jammu Links News
Does Masimo Corporation stock perform well during market downturnsMaximize your portfolio’s growth potential - Jammu Links News
What markets is FMNB expanding into Is Masimo Corporation stock a good long term investment optionAchieve breakthrough financial growth - Jammu Links News
Apple Watch Blood Oxygen Feature Disabled in US Amid Masimo Patent Dispute - WebProNews
Should I hold or sell Masimo Corporation stock in 2025AI Powered Review For 2025 - Jammu Links News
Zacks Research Equities Analysts Lower Earnings Estimates for Masimo Co. (NASDAQ:MASI) - 富途牛牛
What technical models suggest about Masimo Corporation’s comebackDay Trading Signals With High Precision Reviewed - metal.it
Custom Dashboard Highlights Masimo Corporation Price MomentumVerified Signal From Chart Patterns Detected - metal.it
Former Masimo COO Bilal Muhsin Joins BD - Orange County Business Journal
How many analysts rate Masimo Corporation as a “Buy”Capitalize on trading strategies that deliver - Jammu Links News
Is Masimo Corporation stock overvalued or undervaluedBreakthrough investment results - Jammu Links News
What are analysts’ price targets for Masimo Corporation in the next 12 monthsStay informed with daily expert analysis - Jammu Links News
What analysts say about Masimo Corporation stockUnprecedented profit potential - PrintWeekIndia
Envestnet Asset Management Inc. Buys 681 Shares of Masimo Corporation (NASDAQ:MASI) - Defense World
Masimo Corporation Stock Analysis and ForecastExplosive capital appreciation - Autocar Professional
Mark Your Calendar: Masimo Q2 2025 Earnings Call Set for August 5CEO Katie Szyman to Present - Stock Titan
Is Masimo Corporation a good long term investmentRemarkable growth - jammulinksnews.com
Lobbying Update: $110,000 of MASIMO CORPORATION lobbying was just disclosed - Quiver Quantitative
Masimo Corp. Settles Investor Suit Over Revenue Disclosures - Law360
The Impact of Sensor Application Site on Continuous Noninvasive Haemoglobin Trends - ScienceDirect.com
Vontobel Holding Ltd. Has $232,000 Position in Masimo Corporation (NASDAQ:MASI) - Defense World
Samsung to buy US health tech firm Xealth in digital health push - KED Global
Masimo Criticizes Bid To DQ Quinn Emanuel In Payout Suit - Law360
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
1.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):